Summary & Overview
Knee Procedures with Principal Diagnosis of Infection with CC: Inpatient Reimbursement Overview
DRG 486 includes inpatient knee procedures where the principal diagnosis is infection with a Complication or Comorbidity; it encompasses surgical management of infected knees with added clinical complexity. Accurate coding and documentation matter for inpatient reimbursement because the Diagnosis-Related Group determines the fixed Medicare payment reflecting the increased resource use of infected knee cases with Complication or Comorbidity.
DRG 486 Overview
DRG 486 covers knee procedures performed with a principal diagnosis of infection accompanied by a Complication or Comorbidity. This grouping captures inpatient stays where surgical management of an infected knee is required and additional clinical complexity increases resource use. It matters for Medicare payment because the Diagnosis-Related Group assignment drives the prospective fixed payment for the hospital stay, reflecting higher expected costs when infection plus Complication or Comorbidity are present. Appropriate coding of the infection and associated comorbid conditions determines assignment to this Diagnosis-Related Group and the associated reimbursement level.
Clinical Trials
- Acute surgical and perioperative management trials: randomized or prospective studies evaluating timing and extent of surgical intervention (e.g., immediate debridement with implant retention versus staged explant and reimplant) and standardized perioperative care bundles for patients admitted with prosthetic or native knee joint infection. These studies enroll patients at presentation to inpatient services with confirmed knee infection and compare short-term outcomes such as infection eradication, need for repeat operations, length of stay, and perioperative complications; they are relevant because surgical strategy and timing drive resource utilization, device use, and acute inpatient costs for this DRG.
- Comparative effectiveness studies of antibiotic regimens and delivery strategies in the inpatient setting: pragmatic trials or observational comparative-effectiveness research comparing intravenous antibiotic strategies, duration of inpatient IV therapy versus early step-down to outpatient parenteral or oral regimens, and use of local antibiotic carriers in conjunction with surgery. These studies focus on adults hospitalized with septic arthritis or prosthetic joint infection of the knee, often stratified by organism and presence of comorbidities, and are important to providers and payers because antimicrobial strategy impacts length of stay, readmission risk, antimicrobial resistance risk, and overall treatment costs for patients classified under this DRG.
- Post-discharge functional and health-economic outcomes research: cohort studies or randomized trials assessing rehabilitation timing, structured physical therapy programs, patient-reported outcomes, and readmission prevention interventions after hospital discharge following knee infection treatment. These investigations enroll survivors of inpatient treatment (including those with staged arthroplasty or knee fusion) to measure longer-term mobility, quality of life, prosthesis survival, and total cost of care over months to years; results inform care pathways, allocation of post-acute resources, and reimbursement strategies aimed at reducing downstream costs and improving value for this high-risk DRG.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.